1218/5000
I have not written about this asset for a few days. The reason is that according to my knowledge, the technical analysis that I have applied does not correspond to the logic that governs this type of analysis and that puzzles me. Acqua Cannabis subsidiary of RimRock according to the news and available twits, is increasingly solid and focused on the development without limits of its projection. I incline to that line of thought because I read that, since they make their first serious contracts, they begin a stage of relationship production, inventory and tangible sale. They are in process to participate in the field of Phase 1 clinical and pharmaceutical research of certain popular cannabinoid products in the market, with serious and prestigious institutions and endorsed in that purpose for more than 40 years of experience in the scientific field. That said and despite my knowledge, I can not understand clearly, the behavior of the price in the development of RMRK. When I find some sensible answer on the matter, I will share it with you. Meanwhile I follow closely any movement or news about it, because despite my doubts I can not stop believing that RMRK is an asset with a quasi-guaranteed future.